IP Library › Assignment 069436/0937
Patent Assignment
Reel/Frame 069436/0937

Assignment of Assignor's Interest

Recorded: 2024-09-20 Pages: 18
Assignor
CERO THERAPEUTICS, INC.
Executed: 2024-09-20
Assignee
CERO THERAPEUTICS HOLDINGS, INC.
201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (58)
Chimeric Phagocytic Switch Molecules
Application: 62/400,578 →
Chimeric Engulfment Receptor Molecules
Application: 62/445,235 →
Chimeric Engulfment Receptor Molecules
Application: 16/334,224 →
Publication: US 2020/0055917
Chimeric Engulfment Receptor Molecules
Application: 17/400,082 →
Publication: US 2022/0098273
Chimeric Engulfment Receptor Molecules
Application: 18/304,206 →
Chimeric Engulfment Receptor Molecules
Application: 18/527,075 →
Publication: US 2024/0368244
Chimeric Engulfment Receptor Molecules and Methods of Use
Application: 18/322,450 →
Publication: US 2024/0174766
Chimeric Engulfment Receptor Molecules and Methods of Use
Application: 62/563,615 →
Chimeric Engulfment Receptor Molecules and Methods of Use
Application: 62/652,822 →
Chimeric Engulfment Receptor Molecules and Methods of Use
Application: 62/649,529 →
Chimeric Engulfment Receptor Molecules and Methods of Use
Application: 16/646,530 →
Publication: US 2020/0308305
Chimeric TIM4 Receptors and Uses Thereof
Application: 17/040,317 →
Publication: US 2021/0087251
Chimeric TIM4 Receptors and Uses Thereof
Application: 62/649,491 →
Chimeric Engulfment Receptors and Uses Thereof for Neurodegenerative Diseases
Application: 62/649,472 →
Chimeric Engulfment Receptors and Uses Thereof for Neurodegenerative Diseases
Application: 17/040,341 →
Publication: US 2021/0015865
Expression Vectors for Chimeric Engulfment Receptors, Genetically Modified Host Cells, and Uses Thereof
Application: 62/649,499 →
Expression Vectors for Chimeric Engulfment Receptors, Genetically Modified Host Cells, and Uses Thereof
Application: 17/040,464 →
Publication: US 2021/0024607
Cellular Immunotherapy Compositions and Uses Thereof
Application: 17/040,472 →
Publication: US 2021/0023135
Cellular Immunotherapy Compositions and Uses Thereof
Application: 62/649,541 →
Cellular Immunotherapy Compositions and Uses Thereof
Application: 62/734,863 →
Cellular Immunotherapy Compositions and Uses Thereof
Application: 62/652,838 →
Chimeric TIM4 Receptors and Uses Thereof
Application: 63/066,098 →
Chimeric TIM4 Receptors and Uses Thereof
Application: 62/910,133 →
Chimeric TIM4 Receptors and Uses Thereof
Application: 17/766,173 →
Publication: US 2024/0058446
Bivalent Chimeric Engulfment Receptors and Uses Thereof
Application: 17/154,959 →
Publication: US 2021/0253696
Bivalent Chimeric Engulfment Receptors and Uses Thereof
Application: 62/964,105 →
Anti-CD72 Chimeric Receptors and Uses Thereof
Application: 63/066,149 →
Anti-CD72 Chimeric Receptors and Uses Thereof
Application: 18/041,198 →
Anti-CD72 Chimeric Receptors and Uses Thereof
Application: 63/172,057 →
Anti-CD72 Chimeric Receptors and Uses Thereof
Application: 63/226,736 →
Anti-CD72 Chimeric Receptors and Uses Thereof
Application: 18/418,120 →
Publication: US 2024/0285684
Chimeric Tim Receptors and Uses Thereof
Application: 18/041,195 →
Publication: US 2024/0285682
Chimeric Tim Receptors and Uses Thereof
Application: 63/226,643 →
Chimeric Tim Receptors and Uses Thereof
Application: 63/066,085 →
Compositions and Methods for Treating Cancer with Chimeric Tim Receptors in Combination with Inhibitors of Poly (Adp-Ribose) Polymerase
Application: 63/066,150 →
Compositions and Methods for Treating Cancer with Chimeric Tim Receptors in Combination with Inhibitors of Poly (Adp-Ribose) Polymerase
Application: 63/226,712 →
Compositions and Methods for Treating Cancer with Chimeric Tim Receptors in Combination with Inhibitors of Poly (Adp-Ribose) Polymerase
Application: 63/087,049 →
Compositions and Methods for Treating Cancer with Chimeric Tim Receptors in Combination with Inhibitors of Poly (Adp-Ribose) Polymerase
Application: 18/041,200 →
Publication: US 2025/0186491
Compositions and Methods for Enhancing CCR7 Expressing T Cells or CD4/CD8 T Cell Ratio with Chimeric TIM4 Receptors in Combination with Inhibitors of Poly (Adp-Ribose) Polymerase
Application: 63/311,016 →
Anti-CD72 Chimeric Receptors and Uses Thereof
Application: 63/311,045 →
Chimeric Tim Receptors and Uses Thereof
Application: 63/311,042 →
Chimeric Tim Receptors and Uses Thereof
Application: 63/342,031 →
Chimeric Tim Receptors and Uses Thereof
Application: 63/336,980 →
Chimeric TIM4 Receptors and Uses Thereof
Application: 18/292,782 →
Publication: US 2025/0127896
Compositions and Methods for Treating Cancer with Chimeric Tim Receptors in Combination with Inhibitors of Poly (Adp-Ribose) Polymerase
Application: 63/341,999 →
Compositions and Methods for Treating Cancer with Chimeric Tim Receptors in Combination with Inhibitors of Poly (Adp-Ribose) Polymerase
Application: 63/336,972 →
Compositions and Methods for Treating Cancer with Chimeric Tim Receptors in Combination with Inhibitors of Poly (Adp-Ribose) Polymerase
Application: 63/311,043 →
Chimeric Engulfment Receptor Molecules
Chimeric Engulfment Receptor Molecules and Methods of Use
Chimeric TIM4 Receptors and Uses Thereof
Chimeric Engulfment Receptors and Uses Thereof for Neurodegenerative Diseases
Expression Vectors for Chimeric Engulfment Receptors, Genetically Modified Host Cells, and Uses Thereof
Cellular Immunotherapy Compositions and Uses Thereof
Chimeric TIM4 Receptors and Uses Thereof
Anti-CD72 Chimeric Receptors and Uses Thereof
Chimeric Tim Receptors and Uses Thereof
Compositions and Methods for Treating Cancer with Chimeric Tim Receptors in Combination with Inhibitors of Poly (Adp-Ribose) Polymerase
Chimeric TIM4 Receptors and Uses Thereof
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 7, 2017
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC.
Reel/Frame 041197/0500 →
Assignment of Assignor's Interest Feb 7, 2017
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC.
Reel/Frame 041197/0496 →
Assignment of Assignor's Interest Sep 19, 2018
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC.
Reel/Frame 046911/0737 →
Assignment of Assignor's Interest Sep 19, 2018
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC.
Reel/Frame 046911/0441 →
Assignment of Assignor's Interest Sep 20, 2018
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC.
Reel/Frame 046927/0512 →
Assignment of Assignor's Interest Mar 14, 2019
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC.
Reel/Frame 048598/0518 →
Assignment of Assignor's Interest Mar 14, 2019
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC.
Reel/Frame 048598/0239 →
Assignment of Assignor's Interest Mar 15, 2019
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC
Reel/Frame 048610/0492 →
Assignment of Assignor's Interest Mar 18, 2019
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC.
Reel/Frame 048623/0897 →
Assignment of Assignor's Interest Mar 19, 2019
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC.
Reel/Frame 048636/0425 →
Assignment of Assignor's Interest Mar 26, 2019
From: COREY, DANIEL MARK; IBARRA, INGRID
To: CERO THERAPEUTICS, INC.
Reel/Frame 048706/0157 →
Assignment of Assignor's Interest Mar 28, 2019
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC.
Reel/Frame 048732/0172 →
Assignment of Assignor's Interest Sep 28, 2020
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC.
Reel/Frame 053901/0698 →
Assignment of Assignor's Interest Sep 28, 2020
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC.
Reel/Frame 053901/0792 →
Assignment of Assignor's Interest Oct 15, 2020
From: COREY, DANIEL MARK; IBARRA, INGRID
To: CERO THERAPEUTICS, INC.
Reel/Frame 054070/0083 →
Assignment of Assignor's Interest Feb 13, 2023
From: COREY, DANIEL MARK; KIPNISS, NATHAN; KOIDE, YUKIYE; CIENIEWICZ, BRANDON
To: CERO THERAPEUTICS, INC.
Reel/Frame 062680/0135 →
Assignment of Assignor's Interest Feb 13, 2023
From: COREY, DANIEL MARK; KIPNISS, NATHAN
To: CERO THERAPEUTICS, INC.
Reel/Frame 062680/0155 →
Assignment of Assignor's Interest Feb 13, 2023
From: COREY, DANIEL MARK; KIPNISS, NATHAN; KOIDE, YUKIYE; CIENIEWICZ, BRANDON
To: CERO THERAPEUTICS, INC.
Reel/Frame 062680/0081 →
Assignment of Assignor's Interest Feb 13, 2023
From: COREY, DANIEL MARK; KIPNISS, NATHAN; KOIDE, YUKIYE; CIENIEWICZ, BRANDON
To: CERO THERAPEUTICS, INC.
Reel/Frame 062680/0092 →
Assignment of Assignor's Interest Apr 19, 2023
From: COREY, DANIEL MARK
To: CERO THERAPEUTICS, INC.
Reel/Frame 063381/0805 →